Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair
loss ranging from patches on the scalp to complete hair loss involving the entire body …

Importance Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease.
Several studies have reported outcomes of Janus kinase (JAK) inhibitors for treating AA, but …

Alopecia areata is an autoimmune hair loss disease that is non-scarring and is
characterized by chronic inflammation at the hair follicle level. Clinically, patients' …

The JAK-STAT signaling pathway mediates important cellular processes such as immune
response, carcinogenesis, cell differentiation, division and death. Therefore, drugs that …

Alopecia areata (AA) is a chronic, non-scarring, immune-mediated skin disease that affects
approximately 0.5–2% of the global population. The etiology of AA is complex and involves …

Management options for moderate‐to‐severe alopecia areata (AA) are limited owing to a
lack of safe and effective treatments suitable for long‐term use. However, newer agents …

The aim of this study was to compare the efficacy and safety of treatment with Janus kinase
inhibitors for alopecia areata, measured by change in Severity of Alopecia Tool (SALT) …

Janus kinase (JAK) inhibitors have ushered in a new era in alopecia areata (AA).
Historically, moderate-to-severe AA was refractory to treatment. JAK inhibitors have changed …

ABSTRACT Introduction Alopecia Areata (AA) is the second most common non-scarring hair
loss disorder, with a prevalence of 1 in 1000 and a lifetime incidence of 2% worldwide. Data …

Hair-loss diseases comprise heterogenous conditions with respective pathophysiology and
clinicopathological characteristics. Major breakthroughs in hair follicle biology and …